Calithera Biosciences (NASDAQ:CALA) research coverage began at StockNews.com

Equities research analysts at StockNews.com have initiated coverage on the stock Calithera Biosciences (NASDAQ:CALA – Get a Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences stock performance

Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.13. The company has a 50 day moving average price of $0.01 and a two hundred day moving average price of $0.02.

Calithera Biosciences Company Profile

(Get a free report)

Calithera Biosciences, Inc is operating under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in clinical-stage precision oncology biopharmaceuticals. Calithera Biosciences, Inc was founded in 2010 and is headquartered in South San Francisco, California.

Read more

Get news and reviews for Calithera Biosciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Calithera Biosciences and related companies with MarketBeat.com’s FREE daily email newsletter.